In fact, it’s already the fastest drug regulatory agency in the world.
In the 1980s and ’90s, Congress and the FDA created several programs to speed up the development and approval process for new pharmaceuticals: the “orphan drug” designation (for diseases just like Megan’s), priority review, fast track, and accelerated approval.
For example, several studies have found that since the mid-1990s, about 85 to 90 percent of new drugs that have come onto the market don't offer any clinical advantages for patients compared with existing therapies.
And shortly after the vaccine’s introduction, problems with its production resulted in the Cutter Incident: Vaccines with live polio virus (instead of killed virus) were administered to thousands of American children, sickening 40,000, leaving 200 paralyzed, and killing 10.
Hopefully Trump keeps that in mind as he guides the agency to “slash” restraints.